Clobetasol Propionate (Emollient)
Clobetasol Propionate (Emollient) Uses, Dosage, Side Effects, Food Interaction and all others data.
Clobetasol Propionate (Emollient) is under investigation for the treatment of Scleroderma. Clobetasol Propionate (Emollient) has been investigated for the prevention of Psoriasis and Cutaneous Atrophy Due to Corticosteroids.
| Trade Name | Clobetasol Propionate (Emollient) |
| Availability | Prescription only |
| Generic | Clobetasol |
| Clobetasol Other Names | Clobetasol |
| Related Drugs | Humira, Cosentyx, Dupixent, prednisone, doxycycline, methotrexate, betamethasone topical, Remicade, Stelara, cyclosporine |
| Type | |
| Formula | C22H28ClFO4 |
| Weight | Average: 410.907 Monoisotopic: 410.166015296 |
| Groups | Approved, Experimental, Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | USA |
| Last Updated: | September 19, 2023 at 7:00 am |
Clobetasol Propionate (Emollient) Disease Interaction
Moderate: diabetes, diaper rash, hyperadrenocorticism, infections, ocular toxicities
Innovators Monograph
You find simplified version here Clobetasol Propionate (Emollient)
